The candidates vying to be the next London mayor
Enfield Council commits to anti-racism and diversity pledge
President Erdogan promised supporters his party would learn its lessons from the defeat
Mayor of London and London Assembly elections
A Century of Urban Transformation, Istanbul’s Evolution
Future Painters Exhibition at Tottenham Hotspur Stadium
Models of Teaching International Journalism for Sustainable Development
UK and US scientists have been working on eclipse observations
English Premier League leaders Arsenal will visit title contenders
Liverpool meet Atalanta and West Ham face Bayer Leverkusen
Arsenal face Bayern Munich and Manchester City play Real Madrid
UK Transfer deadline day, the transfer window closes tonight
Europe's travel strikes: Flight and train disruption you can expect in April
Enfield Council website achieves digital inclusion recognition
Enfield Council’s Planning Enforcement team goes from strength to strength
UK's first Turkish Shacklewell Lane Mosque faces threat to its future
Britain’s health regulator on Tuesday authorized the use of a Pfizer/BioNTech coronavirus vaccine for infants and children aged six months to 4 years. In a statement, the Medicines and Healthcare products Regulatory Agency (MHRA) said that the Comirnaty COVID vaccine has met its required safety, quality and effectiveness standards.
"This presentation is specially designed for this new age group and given at a lower dose compared to that used in individuals aged 5 to 11 years (3 micrograms compared with 10 micrograms)," MHRA said.
It said that before the decision, the agency reviewed data from an ongoing clinical trial involving 4,526 participants and noted that expected side effects “were in-keeping with what can be anticipated from a vaccine in this age group.”
"It is given as three injections in the upper arm, with the first two doses given 3 weeks apart, followed by a third dose given at least 8 weeks after the second dose," the statement added.
